Tebentafusp
| Tebentafusp | |
|---|---|
| Term | Tebentafusp |
| Short definition | tebentafusp - (pronounced) (teh-BEN-tah-fusp) A drug used to treat adults with uveal melanoma (a type of eye cancer) that has spread or cannot be removed with surgery. It is used in patients who have the HLA-A02:01 antigen. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
tebentafusp - (pronounced) (teh-BEN-tah-fusp) A drug used to treat adults with uveal melanoma (a type of eye cancer) that has spread or cannot be removed with surgery. It is used in patients who have the HLA-A02:01 antigen. It is also being studied in the treatment of other types of cancer. Tebentafusp attaches to specific antigens found on the surface of choroidal melanoma cells and T cells (a type of immune cell). This can help the immune system kill cancer cells. Tebentafusp is a type of bispecific fusion protein. Also called Kimmtrak
External links
- Medical encyclopedia article on Tebentafusp
- Wikipedia's article - Tebentafusp
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski